613 filings
ARS
2023 FY
REGN
Regeneron Pharmaceuticals, Inc.
25 Apr 24
Annual report to shareholders
4:09pm
DEFA14A
REGN
Regeneron Pharmaceuticals, Inc.
25 Apr 24
Additional proxy soliciting materials
4:02pm
DEF 14A
REGN
Regeneron Pharmaceuticals, Inc.
Definitive proxy
25 Apr 24
4:01pm
10-K
2023 FY
REGN
Regeneron Pharmaceuticals, Inc.
Annual report
5 Feb 24
9:16am
8-K
REGN
Regeneron Pharmaceuticals, Inc.
2 Feb 24
Regeneron Reports Fourth Quarter and Full Year 2023 Financial and Operating Results
7:16am
8-K
ojmh5f4up0s4otygpla
31 Jan 24
Departure of Directors or Certain Officers
4:17pm
8-K
w8bj e59zjauxqwlw7
8 Jan 24
2 Strategy & Business Update J.P.Morgan Healthcare Conference 2024 Co - Founder, Board Co - Chair, President & Chief Executive Officer
6:30am
8-K
0pk0ds1uxu1u3i
2 Nov 23
Regeneron Reports Third Quarter 2023 Financial and Operating Results
7:10am
8-K
00vzhfxc
5 Oct 23
Results of Operations and Financial Condition
4:04pm
SC TO-T/A
trk4crqc8dy gaq
25 Sep 23
Third party tender offer statement (amended)
8:48am
SC TO-T/A
j4ztq
12 Sep 23
Third party tender offer statement (amended)
4:38pm
8-K/A
ewqpftjmv
8 Sep 23
Submission of Matters to a Vote of Security Holders
5:00pm
8-K
0vx4ia
8 Sep 23
Departure of Directors or Certain Officers
4:52pm
SC TO-T/A
fjfngo43x9vkofdvb69
8 Sep 23
Third party tender offer statement (amended)
4:05pm
SC TO-T
sjfskv4x
25 Aug 23
Third party tender offer statement
7:46am
SC TO-C
9t48v01r ji8d74s
9 Aug 23
Information about tender offer
4:15pm
8-K
3uk2jdy4 oryhg4
3 Aug 23
Regeneron Reports Second Quarter 2023 Financial and Operating Results
6:48am
8-K
vjnt1qi7vxv3
14 Jun 23
Amendments to Articles of Incorporation or Bylaws
4:07pm